ContractLicense Agreement • November 4th, 2024 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
Certain information (marked as [***]) has been excluded from this exhibit because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.
